We are live on ! Find out more
PACB icon

Pacific Biosciences
PACB

81 hedge funds and large institutions have $184M invested in Pacific Biosciences in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

199% more call options, than puts

Call options by funds: $454K | Put options by funds: $152K

183% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 6

147% more capital invested

Capital invested by funds: $74.4M → $184M (+$109M)

106% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 18

14% more funds holding

Funds holding: 71 → 81 (+10)

Holders
81
Holders Change
+10
Holders Change %
+14.08%
% of All Funds
2.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
37
Reduced
18
Closed
6
Calls
$454K
Puts
$152K
Net Calls
+$302K
Net Calls Change
+$267K

Top Buyers

Rank Fund Capital Flow
1
MC
Maverick Capital
Texas
+$7.92M
2
Millennium Management
Millennium Management
New York
+$5.81M
3
BFA
BlackRock Fund Advisors
California
+$1.28M
4
RFC
Russell Frank Company
Washington
+$1.07M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$737K

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$3.45M
2
RG
Redmile Group
California
-$3.04M
3
BCM
Bridgeway Capital Management
Texas
-$972K
4
Nomura Holdings
Nomura Holdings
Japan
-$788K
5
MHP
Manatuck Hill Partners
Connecticut
-$506K
Name Holding Trade Value Shares
Change 		Change in
Stake
MC
1
Maverick Capital
Texas
$32.1M +$7.92M +2,282,766 +65%
DM
2
Deerfield Management
New York
$27M – – –
Blackstone Inc
3
Blackstone Inc
New York
$13.3M – – –
Millennium Management
4
Millennium Management
New York
$11.7M +$5.81M +1,672,917 +380%
BFA
5
BlackRock Fund Advisors
California
$11.4M +$1.28M +370,015 +22%
OIM
6
Oracle Investment Management
Connecticut
$10.8M – – –
RG
7
Redmile Group
California
$8.71M -$3.04M -876,201 -36%
RCM
8
Raging Capital Management
New Jersey
$5.58M -$86.8K -25,000 -2%
Vanguard Group
9
Vanguard Group
Pennsylvania
$4.36M +$577K +166,198 +27%
BA
10
BlackRock Advisors
Delaware
$3.92M +$14.4K +4,145 +0.6%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$3.78M +$737K +212,184 +45%
Fuller & Thaler Asset Management
12
Fuller & Thaler Asset Management
California
$3.5M -$33K -9,500 -1%
BIT
13
BlackRock Institutional Trust
California
$3.5M +$370K +106,565 +20%
Northern Trust
14
Northern Trust
Illinois
$3.4M +$388K +111,737 +22%
TC
15
TFS Capital
Pennsylvania
$3.08M +$426K +122,840 +28%
State Street
16
State Street
Massachusetts
$3.02M +$19.3K +5,546 +1%
PAM
17
Panagora Asset Management
Massachusetts
$2.97M -$214K -61,761 -10%
California Public Employees Retirement System
18
California Public Employees Retirement System
California
$2.79M – – –
RFC
19
Russell Frank Company
Washington
$1.88M +$1.07M +306,868 +952%
Renaissance Technologies
20
Renaissance Technologies
New York
$1.55M +$14.2K +4,100 +1%
BCM
21
Bridgeway Capital Management
Texas
$1.53M -$972K -280,000 -50%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$1.21M +$191K +55,003 +34%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$1.2M -$3.09K -889 -0.4%
TCIM
24
TIAA CREF Investment Management
New York
$1.19M +$23.4K +6,753 +3%
EI
25
EAM Investors
California
$1.12M +$705K +203,176 New
1
2 3 4

PACB Hedge Fund Activity: Q3 2013 in Review

81 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q3 2013, worth a combined $184M — up 147% from $74.4M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PACB positions and 6 closed out — a net gain of 11 holders — while 37 added to existing stakes and 18 trimmed.

The largest buyer was Maverick Capital, adding an estimated $7.92M. The largest seller was Visium Asset Management, cutting an estimated $3.45M.

  • 81 institutional investors held Pacific Biosciences (PACB) as of Q3 2013, up from 71 in Q2 2013.
  • Funds reported $184M of Pacific Biosciences stock for Q3 2013, up 147% quarter-over-quarter.
  • 17 funds opened new Pacific Biosciences positions in Q3 2013 and 6 closed out, a net change of +11 holders.
  • The largest Pacific Biosciences buyer in Q3 2013 was Maverick Capital, an estimated $7.92M added.
  • The largest Pacific Biosciences seller in Q3 2013 was Visium Asset Management, an estimated $3.45M sold.

Based on aggregated 13F filings for Q3 2013.